BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $57,000 | +42.5% | 9,000 | 0.0% | 0.01% | +37.5% |
| Q3 2016 | $40,000 | +53.8% | 9,000 | 0.0% | 0.01% | +33.3% |
| Q2 2016 | $26,000 | +4.0% | 9,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $25,000 | -73.1% | 9,000 | 0.0% | 0.01% | -73.9% |
| Q4 2015 | $93,000 | -9.7% | 9,000 | 0.0% | 0.02% | -14.8% |
| Q3 2015 | $103,000 | -42.5% | 9,000 | -25.0% | 0.03% | -41.3% |
| Q2 2015 | $179,000 | +65.7% | 12,000 | 0.0% | 0.05% | +70.4% |
| Q1 2015 | $108,000 | -26.0% | 12,000 | 0.0% | 0.03% | -30.8% |
| Q4 2014 | $146,000 | +24.8% | 12,000 | 0.0% | 0.04% | +8.3% |
| Q3 2014 | $117,000 | -23.5% | 12,000 | 0.0% | 0.04% | -25.0% |
| Q2 2014 | $153,000 | +20.5% | 12,000 | 0.0% | 0.05% | +11.6% |
| Q1 2014 | $127,000 | +39.6% | 12,000 | 0.0% | 0.04% | +30.3% |
| Q4 2013 | $91,000 | +4.6% | 12,000 | 0.0% | 0.03% | -8.3% |
| Q3 2013 | $87,000 | +357.9% | 12,000 | 0.0% | 0.04% | +300.0% |
| Q2 2013 | $19,000 | +35.7% | 12,000 | 0.0% | 0.01% | +28.6% |
| Q1 2013 | $14,000 | -17.6% | 12,000 | 0.0% | 0.01% | -36.4% |
| Q4 2012 | $17,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |